Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Levetiracetam in Japanese Subjects with Renal Impairment
NCT01491113Phase 4Completed
- Sponsor
- UCB
- Start
- Nov 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of levetiracetam in epilepsy (5 arms), sponsored by UCB. Primary endpoints: Maximum Observed Plasma Concentration at 144 hours and Area Under the Concentration-time Curve from Baseline to Last Quantifiable Concentration at 144 hours. Started Nov 2011; status: completed.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01491113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01491113.